NYSE:CNS

Cohn & Steers Stock News

Financial Services > Asset Management

Buy CNS

*Your capital is at risk

$70.20

-1.00 (-1.40%)

At Close: Jun 03, 2026

Cohen & Steers Closed-End Funds Declare Distributions for April, May and June 2026

05:06pm, Tuesday, 24'th Mar 2026

NEW YORK, March 24, 2026 /PRNewswire/ -- The Board of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for April, May and June 2026, as summarized in the char

What Active REIT Managers Bought And Sold In Q4 2025

07:15am, Saturday, 21'st Mar 2026

Top REIT investors are quietly repositioning their portfolios, revealing where the “smart money” sees opportunity. Several clear sector themes are emerging from recent 13F filings. But the biggest

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain

11:37am, Wednesday, 18'th Mar 2026

Superstring Capital Management purchased 37,433 shares of Axsome Therapeutics in the fourth quarter. The quarter-end position value was $6.84 million, representing a new holding in Axsome Therapeutics

Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum

08:03am, Friday, 13'th Mar 2026

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medici

Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum

04:05pm, Thursday, 12'th Mar 2026

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at the Stifel 2026 Virtual CNS Forum on Tuesday, March 17, 2026 at 8:

Korsana Biosciences to Present at the Stifel 2026 Virtual CNS Forum

08:00am, Thursday, 12'th Mar 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegener

LG CNS and Palantir Announce Strategic Partnership to Accelerate AI Transformation

07:00pm, Wednesday, 11'th Mar 2026

MIAMI & SEOUL, South Korea--(BUSINESS WIRE)--LG CNS Co., Ltd. and Palantir Technologies Inc. (NASDAQ: PLTR), a leading provider of AI operating systems, today announced a deepened strategic partnershi

JHG vs. CNS: Which Stock Is the Better Value Option?

12:42pm, Wednesday, 11'th Mar 2026

Investors with an interest in Financial - Investment Management stocks have likely encountered both Janus Henderson Group plc (JHG) and Cohen & Steers Inc (CNS). But which of these two stocks offers v

Cohen & Steers Announces Plan to Convert the Cohen & Steers Future of Energy Fund to ETF

09:12am, Wednesday, 11'th Mar 2026

NEW YORK, March 11, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today announced plans to convert the Cohen & Steers Future of Energy Fund, a U.S. mutual fund designed to capitalize on opport

CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline

08:35am, Wednesday, 11'th Mar 2026

Newly formed executive team initiates global search for differentiated therapeutic assets for neurology and oncology indications, two of biopharma's largest and fastest-growing markets Strategic trans

ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION

08:30am, Wednesday, 11'th Mar 2026

SARASOTA, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal d

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by